共 81 条
- [1] Kountchev J(2005)Reduction of D-dimer levels after therapeutic administration of antithrombin in acquired antithrombin deficiency of severe sepsis Crit Care 9 R596-R600
- [2] Bijuklic K(2001)Role of coagulation inhibitors in inflammation Thromb Haemost 86 51-56
- [3] Bellmann R(2001)Rationale for restoration of physiological anticoagulant pathways in patients with sepsis and disseminated intravascular coagulation Crit Care Med 29 S90-94
- [4] Wiedermann CJ(1996)Factor VIIa and antithrombin III activity during severe sepsis and septic shock in neutropenic patients Blood 88 881-886
- [5] Joannidis M(1992)Septic shock, multiple organ failure, and disseminated intravascular coagulation. Compared patterns of antithrombin III, protein C, and protein S deficiencies [see comments] Chest 101 816-823
- [6] Esmon CT(2000)Recombinant human antithrombin III improves survival and attenuates inflammatory responses in baboons lethally challenged with Escherichia coli Blood 95 1117-1123
- [7] Levi M(2001)Efficacy and safety of recombinant human activated protein C for severe sepsis N Engl J Med 344 699-709
- [8] de Jonge E(1999)Disseminated intravascular coagulation: State of the art Thromb Haemost 82 695-705
- [9] van der Poll T(2001)Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial J Am Med Assoc 286 1869-1878
- [10] Mesters RM(1985)Substitution of antithrombin III in shock and DIC: a randomized study Thromb Res 39 81-89